Defense-electronics names caught the Northrop earnings bid while the battery rung set both extremes, with Ultralife leading ahead of its Thursday print.

The leader was Ultralife (ULBI), up 3.8% to $6.29 on the batteries chokepoint — the energy rung that powers everything an airframe carries but rarely moves the tape. The gain was positioning rather than a dated event: Ultralife reports third-quarter results before the open on Thursday, October 22, and carries a record backlog of roughly $117.5 million built on commercial and government-defense demand, with wearable-defense, counter-UAS and thin-cell programs cited as moving toward 2027 production. There was no company announcement on the session, so the move reads as pre-print interest in the one domestic cell supplier whose order book is already defense-weighted.

The laggard was Enovix (ENVX), down 4.3% to $2.25 on the same batteries chokepoint — the opposite end of it. There was no fresh catalyst; the silicon-anode name kept bleeding on heavy short interest after its August CEO change, giving back ground even against its recent 100,000-unit purchase order from a dual-use drone-systems provider slated for the first half of 2027. The structural read is unchanged: the drone-battery thesis is a 2027 production story, and the tape is pricing the gap between order books and shipped revenue.

The session's real signal was in the defense-electronics core, which caught the bid from Northrop Grumman's earnings beat (detailed on the space desk). The comms, datalink and interceptor primes firmed — L3Harris (LHX) +2.0% to $248.77, Teledyne (TDY) +2.0% to $632.21, RTX +0.6% to $193.34 — while the EO/IR sensing rung lagged: Leonardo DRS (DRS) −3.5% to $33.94 and Umicore's ADR (UMICY) −3.7% to $5.17 on its last session. Airframe-prime Red Cat (RCAT) fell 3.4% to $4.52 and AeroVironment (AVAV) was flat at $117.63. The rare-earth-magnet rung, the supply strait that gates every motor and actuator, split: Lynas (LYSCF) +2.2% to $7.95 on its last session against MP Materials (MP) +0.3% to $39.05.

The hard catalysts ahead are policy-dated and sit on the magnet chokepoint. China's one-year suspension of its October 2025 rare-earth export controls expires November 10, and the separate suspension of the gallium, germanium and antimony ban to the US lapses November 27 — two cliffs that would reprice the entire NDAA-compliant supply rung if they are allowed to bind. Further out, the FAA's Part 108 BVLOS final rule is expected by December 31, the regulatory unlock the commercial-airframe names have waited on. Nearer still, Ultralife's Thursday print is the next company-level test.